Global ctDNA Detection Kit Supply, Demand and Key Producers, 2023-2029

Global ctDNA Detection Kit Supply, Demand and Key Producers, 2023-2029

The global ctDNA Detection Kit market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Circulating tumor DNA (ctDNA) detection, the so-called "liquid biopsy". ctDNA refers to DNA released by tumor cells into the blood circulation system, which contains tumor-derived mutation and genetic variation information. ctDNA is a tumor marker with broad application prospects, high sensitivity and specificity, and is suitable for a variety of tumors, providing opportunities for non-invasive tumor sampling.

This report studies the global ctDNA Detection Kit production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for ctDNA Detection Kit, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of ctDNA Detection Kit that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global ctDNA Detection Kit total production and demand, 2018-2029, (K Units)

Global ctDNA Detection Kit total production value, 2018-2029, (USD Million)

Global ctDNA Detection Kit production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global ctDNA Detection Kit consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: ctDNA Detection Kit domestic production, consumption, key domestic manufacturers and share

Global ctDNA Detection Kit production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global ctDNA Detection Kit production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global ctDNA Detection Kit production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global ctDNA Detection Kit market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grail, Inc., Guardant Health, Inc., Biodesix, Inc., Exosome Diagnostics, Freenome Inc., LungLife AI, Inc., Inivata Ltd., Personal Genome Diagnostics, Inc. and CellMax Life, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World ctDNA Detection Kit market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global ctDNA Detection Kit Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global ctDNA Detection Kit Market, Segmentation by Type
Quantitative Testing
Qualitative Testing

Global ctDNA Detection Kit Market, Segmentation by Application
Hospital
Clinic
Other

Companies Profiled:
Grail, Inc.
Guardant Health, Inc.
Biodesix, Inc.
Exosome Diagnostics
Freenome Inc.
LungLife AI, Inc.
Inivata Ltd.
Personal Genome Diagnostics, Inc.
CellMax Life
Nonacus

Key Questions Answered

1. How big is the global ctDNA Detection Kit market?

2. What is the demand of the global ctDNA Detection Kit market?

3. What is the year over year growth of the global ctDNA Detection Kit market?

4. What is the production and production value of the global ctDNA Detection Kit market?

5. Who are the key producers in the global ctDNA Detection Kit market?